Richard C. Becker

Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

Udaya S. Tantry, Laurent Bonello, Dániel Aradi et al. · Journal of the American College of Cardiology · 2013 · 897 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Platelet Inhibition with Cangrelor in Patients Undergoing PCI

Robert A. Harrington, Gregg W. Stone, Steven E. McNulty et al. · New England Journal of Medicine · 2009 · 618 citations · Full text

Medicine, Cardiology, Pharmacology +16

Seasonal Distribution of Acute Myocardial Infarction in the Second National Registry of Myocardial Infarction 11The National Registry of Myocardial Infarction is supported by Genentech, Inc., South San Francisco, California. Genentech, Inc. reimburses ClinTrials Research, Inc. for the cost of data analysis and biostatistical services.

Frederick A. Spencer, Robert J. Goldberg, Richard C. Becker et al. · Journal of the American College of Cardiology · 1998 · 484 citations

Medicine, Biostatistics, Cardiology +8

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

Richard C. Becker, David J. Moliterno, Lisa K. Jennings et al. · The Lancet · 2009 · 297 citations

Medicine, Cardiology, Pharmacotherapy +10

A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial

Christopher P. Cannon, Carolyn H. McCabe, Timothy D. Henry et al. · Journal of the American College of Cardiology · 1994 · 258 citations

Medicine, Cardiology, Pharmacotherapy +15